{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/1b454f3a-002e-540e-82a0-3e5bcb0b5da9/0a3f6d7f-c943-41b5-ac9d-36e6302958b1?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"HIV infection may raise risk of cocaine abuse","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9f3bd1a8cbe2b563cedcd/1674659784850-2ede8148bf53faf1cecfe09ee0fead3a.jpeg?height=200","description":"Although psychostimulant abusers comprise one of the fastest growing populations of HIV-infected patients, relatively little is known about how HIV may impact the rewarding effects of abused drugs. Dr. Jay P. McLaughlin discusses how a protein associated with HIV infection, called HIV-1 Tat, may increase vulnerability for drug addiction. His research shows that mice who express HIV-1 Tat display an enhanced sensitivity to the rewarding properties of cocaine. The results suggest that just as addiction raises the risk of HIV, HIV may raise the risk of addiction.<img src=\"http://feeds.feedburner.com/~r/npp/podcast/current/~4/bCZtXyfX6Qc\" height=\"1\" width=\"1\" alt=\"\"/>","author_name":"Springer Nature"}